Literature DB >> 11884419

Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells.

Scott H Robbins1, Khuong B Nguyen, Nobuaki Takahashi, Toshifumi Mikayama, Christine A Biron, Laurent Brossay.   

Abstract

The killer cell lectin-like receptor G1 (KLRG1) is the mouse homolog of the rat mast cell function-associated Ag and contains an immunoreceptor tyrosine-based inhibitory motif in its cytoplasmic domain. In this study we demonstrate that both pathogenic and nonpathogenic in vivo activation of NK cells induces the expression of KLRG1 on their cell surface. Upon infection with murine CMV, this induction peaks between days 5 and 7 with about 90% of the NK cells expressing KLRG1. On day 1.5 post-murine CMV infection of C57BL/6 mice, the main producers of IFN-gamma are the KLRG1-negative NK cells. This effect has been recapitulated in vitro as we show that engagement of KLRG1 on a transfected NK cell line inhibits both cytokine production and NK cell-mediated cytotoxicity. Taken together, these data illustrate the crucial role played by KLRG1 during the termination of mouse NK cell activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884419     DOI: 10.4049/jimmunol.168.6.2585

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  A unique lymphotoxin {alpha}beta-dependent pathway regulates thymic emigration of V{alpha}14 invariant natural killer T cells.

Authors:  Ann Sophie Franki; Katrien Van Beneden; Pieter Dewint; Kirsten J L Hammond; Stijn Lambrecht; Georges Leclercq; Mitchell Kronenberg; Dieter Deforce; Dirk Elewaut
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

2.  Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.

Authors:  Kutlu G Elpek; Mark P Rubinstein; Angelique Bellemare-Pelletier; Ananda W Goldrath; Shannon J Turley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 3.  KLRG1--more than a marker for T cell senescence.

Authors:  Sian M Henson; Arne N Akbar
Journal:  Age (Dordr)       Date:  2009-12

4.  Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition.

Authors:  Yili Li; Maike Hofmann; Qian Wang; Leslie Teng; Lukasz K Chlewicki; Hanspeter Pircher; Roy A Mariuzza
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

5.  Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling.

Authors:  Cindy Banh; Céline Fugère; Laurent Brossay
Journal:  Blood       Date:  2009-10-23       Impact factor: 22.113

6.  Markers of nonselective and specific NK cell activation.

Authors:  Leslie A Fogel; Michel M Sun; Theresa L Geurs; Leonidas N Carayannopoulos; Anthony R French
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

Review 7.  Cell-surface molecule-mediated cell-cell interactions in the regulation of ILC2-driven allergic inflammation.

Authors:  Aihua Lei; Jie Zhou
Journal:  Cell Mol Life Sci       Date:  2019-07-16       Impact factor: 9.261

8.  Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.

Authors:  Lucas Souza Ferreira; Deivys Leandro Portuondo; Marisa Campos Polesi; Iracilda Zeppone Carlos
Journal:  Immunology       Date:  2018-08-14       Impact factor: 7.397

9.  Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation.

Authors:  Molly P Keppel; Liping Yang; Megan A Cooper
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

10.  NK cell maturation and function in C57BL/6 mice are altered by caloric restriction.

Authors:  Jonathan F Clinthorne; Eleni Beli; David M Duriancik; Elizabeth M Gardner
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.